EARNINGS PER SHARE	9 Months Ended
Sep. 30, 2026
Earnings Per Share [Abstract]
EARNINGS PER SHARE	EARNINGS PER SHARE We compute earnings per share based upon the treasury stock method. Earnings per share is computed using both basic shares and diluted shares. The difference between basic and diluted shares is that diluted shares include the dilutive effect of the assumed vesting of outstanding securities. Our stock-settled long-term performance awards, restricted stock units and Employee Stock Purchase Plan (“ESPP”) could impact the diluted shares. The difference between basic and diluted shares was approximately 0.9 million and 1.1 million in the third quarter and first nine months of 2026, respectively, and 1.4 million and 1.3 million in the third quarter and first nine months of 2025, respectively, and resulted from the dilutive effect of our stock-based awards. Securities that could potentially be dilutive are excluded from the computation of diluted earnings per share when a loss from continuing operations exists or when the grant price exceeds the market value of our Class A Common Stock because their inclusion would result in an anti-dilutive effect on per share amounts. There were no anti-dilutive restricted stock units, stock-settled long-term performance awards or shares estimated to be purchased under the ESPP excluded from the computation of diluted earnings per share in the third quarters and first nine months of 2026 and 2025, respectively.

EARNINGS PER SHARE

9 Months Ended

Sep. 30, 2026

We compute earnings per share based upon the treasury stock method. Earnings per share is computed using both basic shares and diluted shares. The difference between basic and diluted shares is that diluted shares include the dilutive effect of the assumed vesting of outstanding securities. Our stock-settled long-term performance awards, restricted stock units and Employee Stock Purchase Plan (“ESPP”) could impact the diluted shares. The difference between basic and diluted shares was approximately 0.9 million and 1.1 million in the third quarter and first nine months of 2026, respectively, and 1.4 million and 1.3 million in the third quarter and first nine months of 2025, respectively, and resulted from the dilutive effect of our stock-based awards.

Securities that could potentially be dilutive are excluded from the computation of diluted earnings per share when a loss from continuing operations exists or when the grant price exceeds the market value of our Class A Common Stock because their inclusion would result in an anti-dilutive effect on per share amounts.

There were no anti-dilutive restricted stock units, stock-settled long-term performance awards or shares estimated to be purchased under the ESPP excluded from the computation of diluted earnings per share in the third quarters and first nine months of 2026 and 2025, respectively.